CMS oncology care model names NCCN guidelines as high-quality care and evidence-based recommendations.

To participate in the OCM, participating practices will be required to treat patients with therapies consistent with nationally recognized clinical practice guidelines, such as those published by the National Comprehensive Cancer Network ® (NCCN ® ) and American Society of Clinical Oncology (ASCO), reporting both when patients are and are not treated in concordance with such recommendations. One reason for deviation from clinical guidelines, according to CMS, is participation in a clinical trial. 2 Participation in clinical trials is considered concordant care with the recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ).